These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30858027)

  • 41. Design, synthesis, and biological evaluation of a novel indoleamine 2,3-dioxigenase 1 (IDO1) and thioredoxin reductase (TrxR) dual inhibitor.
    Fan QZ; Zhou J; Zhu YB; He LJ; Miao DD; Zhang SP; Liu XP; Zhang C
    Bioorg Chem; 2020 Dec; 105():104401. PubMed ID: 33113415
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A highly potent and selective inhibitor Roxyl-WL targeting IDO1 promotes immune response against melanoma.
    Xu G; Wang T; Li Y; Huang Z; Wang X; Zheng J; Yang S; Fan Y; Xiang R
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1089-1094. PubMed ID: 29932010
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, synthesis, and biological evaluation of 1,2,5-oxadiazole-3-carboximidamide derivatives as novel indoleamine-2,3-dioxygenase 1 inhibitors.
    Song X; Sun P; Wang J; Guo W; Wang Y; Meng LH; Liu H
    Eur J Med Chem; 2020 Mar; 189():112059. PubMed ID: 31981851
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and activity of novel indirubin derivatives.
    Sun B; Wang J; Liu L; Mao L; Peng L; Wang Y
    Chem Biol Drug Des; 2021 Mar; 97(3):565-571. PubMed ID: 32914538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening.
    Guo W; Yao S; Sun P; Yang TB; Tang CP; Zheng MY; Ye Y; Meng LH
    Acta Pharmacol Sin; 2020 Mar; 41(3):423-431. PubMed ID: 31197246
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase Inhibitors.
    Peng YH; Liao FY; Tseng CT; Kuppusamy R; Li AS; Chen CH; Fan YS; Wang SY; Wu MH; Hsueh CC; Chang JY; Lee LC; Shih C; Shia KS; Yeh TK; Hung MS; Kuo CC; Song JS; Wu SY; Ueng SH
    J Med Chem; 2020 Feb; 63(4):1642-1659. PubMed ID: 31961685
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1).
    Fung SP; Wang H; Tomek P; Squire CJ; Flanagan JU; Palmer BD; Bridewell DJ; Tijono SM; Jamie JF; Ching LM
    Bioorg Med Chem; 2013 Dec; 21(24):7595-603. PubMed ID: 24262887
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nitrobenzofurazan derivatives of N'-hydroxyamidines as potent inhibitors of indoleamine-2,3-dioxygenase 1.
    Paul S; Roy A; Deka SJ; Panda S; Trivedi V; Manna D
    Eur J Med Chem; 2016 Oct; 121():364-375. PubMed ID: 27267006
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New Inhibitors of Indoleamine 2,3-Dioxygenase 1: Molecular Modeling Studies, Synthesis, and Biological Evaluation.
    Coluccia A; Passacantilli S; Famiglini V; Sabatino M; Patsilinakos A; Ragno R; Mazzoccoli C; Sisinni L; Okuno A; Takikawa O; Silvestri R; La Regina G
    J Med Chem; 2016 Nov; 59(21):9760-9773. PubMed ID: 27690429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The [1,2,4]Triazolo[4,3-a]pyridine as a New Player in the Field of IDO1 Catalytic Holo-Inhibitors.
    Fallarini S; Bhela IP; Aprile S; Torre E; Ranza A; Orecchini E; Panfili E; Pallotta MT; Massarotti A; Serafini M; Pirali T
    ChemMedChem; 2021 Nov; 16(22):3439-3450. PubMed ID: 34355531
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 1,2,3-Triazoles as inhibitors of indoleamine 2,3-dioxygenase 2 (IDO2).
    Röhrig UF; Majjigapu SR; Caldelari D; Dilek N; Reichenbach P; Ascencao K; Irving M; Coukos G; Vogel P; Zoete V; Michielin O
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4330-3. PubMed ID: 27469130
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of a Novel Scaffold as an Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Based on the Pyrrolopiperazinone Alkaloid, Longamide B.
    Shiokawa Z; Kashiwabara E; Yoshidome D; Fukase K; Inuki S; Fujimoto Y
    ChemMedChem; 2016 Dec; 11(24):2682-2689. PubMed ID: 27863031
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent discovery of indoleamine-2,3-dioxygenase 1 inhibitors targeting cancer immunotherapy.
    Weng T; Qiu X; Wang J; Li Z; Bian J
    Eur J Med Chem; 2018 Jan; 143():656-669. PubMed ID: 29220788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Azole-Based Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
    Röhrig UF; Majjigapu SR; Reynaud A; Pojer F; Dilek N; Reichenbach P; Ascencao K; Irving M; Coukos G; Vogel P; Michielin O; Zoete V
    J Med Chem; 2021 Feb; 64(4):2205-2227. PubMed ID: 33557523
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design, synthesis and antitumor study of a series of N-Cyclic sulfamoylaminoethyl substituted 1,2,5-oxadiazol-3-amines as new indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors.
    Chen S; Guo W; Liu X; Sun P; Wang Y; Ding C; Meng L; Zhang A
    Eur J Med Chem; 2019 Oct; 179():38-55. PubMed ID: 31233921
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of immunosuppressive indoleamine 2,3-dioxygenase by targeting the heme and apo-form.
    Pradhan N; Akhtar N; Nath B; Peña-García J; Gupta A; Pérez-Sánchez H; Kumar S; Manna D
    Chem Commun (Camb); 2021 Jan; 57(3):395-398. PubMed ID: 33326535
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of a series of novel o-phenylenediamine-based indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
    Williams DK; Markwalder JA; Balog AJ; Chen B; Chen L; Donnell J; Haque L; Hart AC; Mandal SK; Nation A; Shan W; Vite GD; Covello K; Hunt JT; Jure-Kunkel MN; Seitz SP
    Bioorg Med Chem Lett; 2018 Feb; 28(4):732-736. PubMed ID: 29398543
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery of cyanopyridine scaffold as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors through virtual screening and preliminary hit optimisation.
    Xu X; Ren J; Ma Y; Liu H; Rong Q; Feng Y; Wang Y; Cheng Y; Ge R; Li Z; Bian J
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):250-263. PubMed ID: 30734612
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery of novel hydroxyamidine derivatives as indoleamine 2,3-dioxygenase 1 inhibitors with in vivo anti-tumor efficacy.
    Liu C; Nan Y; Xia Z; Gu K; Chen C; Dong X; Ju D; Zhao W
    Bioorg Med Chem Lett; 2020 Apr; 30(8):127038. PubMed ID: 32088128
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, synthesis and biological evaluation of novel aryl-acrylic derivatives as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors.
    Hu H; Li M; Wu D; Li Z; Miao R; Liu Y; Gong P
    Bioorg Med Chem; 2019 Jul; 27(14):3135-3144. PubMed ID: 31178268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.